Pharmaceutical / Drug Definition :
Blocks stimulation of beta1- and beta2-adrenergic receptor sites and alpha1-adrenergic receptors, decreasing myocardial contractile force and enhancing coronary artery blood flow and myocardial perfusion. Net effect is decreased heart rate and blood pressure.
FDA Label Requirements and Exceptions
Labetalol Hydrochloride
FDA Import Information
Labetalol Hydrochloride
FDA Detentions
Labetalol Hydrochloride (Labetalol Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Labetalol Hydrochloride (Labetalol Hydrochloride Suppliers)
- Processors Labetalol Hydrochloride
- Repackers Labetalol Hydrochloride
- Relabelers Labetalol Hydrochloride
- Exporters Labetalol Hydrochloride
- Importers Labetalol Hydrochloride
For more information about Labetalol Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
